⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RLMD News
Relmada Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
RLMD
Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer
globenewswire.com
RLMD
Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
globenewswire.com
RLMD
Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes
globenewswire.com
RLMD
Relmada Therapeutics Appoints CNS Drug Development Veteran Michael Quirk as Senior Advisor for Sepranolone Program
globenewswire.com
RLMD
Form 8-K
sec.gov
RLMD
Relmada Therapeutics to Present at the Jefferies Global Healthcare Conference
globenewswire.com
RLMD
Form 8-K
sec.gov
RLMD
Relmada Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
globenewswire.com
RLMD
Relmada Therapeutics to Report First Quarter 2026 Financial Results on Tuesday, May 12, 2026
globenewswire.com
RLMD